Skip to main content
Erschienen in: AIDS and Behavior 3/2024

04.10.2023 | Original Paper

Changes in Adherence and Viral Load Suppression Among People with HIV in Manila: Outcomes of the Philippines Connect for Life Study

verfasst von: Cara O’Connor, Katerina Leyritana, Aoife M. Doyle, James J. Lewis, Edsel Maurice Salvaña

Erschienen in: AIDS and Behavior | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

The Philippines HIV epidemic is among the fastest growing globally. Infections among men who have sex with men are rising at an alarming rate, necessitating targeted evidence-based interventions to retain people living with HIV in care, support adherence, and reach viral suppression. We conducted a 48-week prospective cohort study of 462 participants in which we provided a mobile health (mHealth) adherence support intervention using the Connect for Life platform. We observed an improvement in adherence, with the proportion of participants taking more than 95% of their antiretroviral therapy (ART) doses increasing from 78.6% at baseline to 90.3% at 48 weeks. Among treatment experienced participants, adherence improved significantly (McNemar’s test = 21.88, P < 0.001). Viral load suppression did not change, with 92.6% suppression at baseline and 92.0% at 48 weeks. Illicit drug use was associated with reduced adherence (aOR = 0.56, 95%CI 0.31–1.00, P = 0.05) and being on second-line therapy was associated with poor viral load suppression (aOR = 0.33, 95%CI 0.14–0.78, P = 0.01). Quality of life improved following ART initiation, from a mean of 84.6 points (of a possible 120) at baseline to 91.01 at 48 weeks. Due to technical issues, fidelity to the intended intervention was low, with 22.1% (102/462) of participants receiving any voice calls and most others receiving a scaled-back SMS intervention. The mHealth intervention did not have any observed effect on adherence or on viral load suppression. While evidence of effectiveness of mHealth adherence interventions is mixed, these platforms should continue to be explored as part of differentiated treatment support services.
Literatur
1.
Zurück zum Zitat Joint United Nations Programme on HIV/AIDS (UNAIDS). Philippines country data 2020. 2020. Joint United Nations Programme on HIV/AIDS (UNAIDS). Philippines country data 2020. 2020.
2.
Zurück zum Zitat National HIV/AIDS & STI Surveillance and Strategic Information Unit. HIV/AIDS and ART Registry of the Philippines (HARP) report March 2022. Manila: National HIV/AIDS & STI Surveillance and Strategic Information Unit; 2022. National HIV/AIDS & STI Surveillance and Strategic Information Unit. HIV/AIDS and ART Registry of the Philippines (HARP) report March 2022. Manila: National HIV/AIDS & STI Surveillance and Strategic Information Unit; 2022.
3.
Zurück zum Zitat UNAIDS. The global AIDS strategy 2021–2026. Geneva: UNAIDS; 2021. UNAIDS. The global AIDS strategy 2021–2026. Geneva: UNAIDS; 2021.
4.
Zurück zum Zitat UNAIDS. Country factsheets: Philippines. AIDSinfo. Geneva: UNAIDS; 2021. UNAIDS. Country factsheets: Philippines. AIDSinfo. Geneva: UNAIDS; 2021.
5.
Zurück zum Zitat Eustaquio PC, Docken SS, Leyritana KT, Wulandari LPL. HIV care cascade among cisgender men who have sex with men in a key population-led community center in the Philippines. Int J STD AIDS. 2021;32(8):718–28.PubMedCrossRef Eustaquio PC, Docken SS, Leyritana KT, Wulandari LPL. HIV care cascade among cisgender men who have sex with men in a key population-led community center in the Philippines. Int J STD AIDS. 2021;32(8):718–28.PubMedCrossRef
6.
Zurück zum Zitat Philippine Health Insurance Corporation. Outpatient HIV/AIDS treatment (OHAT) package (revision 2). 2021. Philippine Health Insurance Corporation. Outpatient HIV/AIDS treatment (OHAT) package (revision 2). 2021.
7.
Zurück zum Zitat Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodríguez E, Warren MR, Vejo J. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–96.PubMedCrossRef Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodríguez E, Warren MR, Vejo J. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–96.PubMedCrossRef
8.
Zurück zum Zitat Jiamsakul A, Kumarasamy N, Ditangco R, Li PCK, Phanuphak P, Sirisanthana T, Sungkanuparph S, Kantipong P, Lee CKC, Mustafa M, Merati TP, Kamarulzaman A, Singtoroj T, Law M. Factors associated with suboptimal adherence to antiretroviral therapy in Asia. J Int AIDS Soc. 2014;17:1–9.CrossRef Jiamsakul A, Kumarasamy N, Ditangco R, Li PCK, Phanuphak P, Sirisanthana T, Sungkanuparph S, Kantipong P, Lee CKC, Mustafa M, Merati TP, Kamarulzaman A, Singtoroj T, Law M. Factors associated with suboptimal adherence to antiretroviral therapy in Asia. J Int AIDS Soc. 2014;17:1–9.CrossRef
9.
Zurück zum Zitat Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–66.PubMedCrossRef Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–66.PubMedCrossRef
10.
Zurück zum Zitat Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N, Hudson B. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.PubMedCrossRef Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N, Hudson B. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.PubMedCrossRef
11.
Zurück zum Zitat Ammassari A, Trotta MP, Shalev N, Marconi P, Antinori A. Beyond virological suppression: the role of adherence in the late HAART era. Antivir Ther. 2012;17(5):785–92.PubMedCrossRef Ammassari A, Trotta MP, Shalev N, Marconi P, Antinori A. Beyond virological suppression: the role of adherence in the late HAART era. Antivir Ther. 2012;17(5):785–92.PubMedCrossRef
12.
Zurück zum Zitat Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and virologic failure: a meta-analysis. Medicine. 2016;95(15):e3361.PubMedPubMedCentralCrossRef Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and virologic failure: a meta-analysis. Medicine. 2016;95(15):e3361.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43(7):939–41.PubMedCrossRef Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43(7):939–41.PubMedCrossRef
14.
Zurück zum Zitat Harrigan PR, Hogg RS, Dong WWY, Yip B, Wynhoven B, Woodward J, Brumme CJ, Brumme ZL, Mo T, Alexander CS, Montaner JSG. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191(3):339–47.PubMedCrossRef Harrigan PR, Hogg RS, Dong WWY, Yip B, Wynhoven B, Woodward J, Brumme CJ, Brumme ZL, Mo T, Alexander CS, Montaner JSG. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191(3):339–47.PubMedCrossRef
15.
Zurück zum Zitat Tam LWY, Chui CKS, Brumme CJ, Bangsberg DR, Montaner JSG, Hogg RS, Harrigan PR. The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes. J Acquir Immune Defic Syndr. 2008;49(3):266–71.PubMedPubMedCentralCrossRef Tam LWY, Chui CKS, Brumme CJ, Bangsberg DR, Montaner JSG, Hogg RS, Harrigan PR. The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes. J Acquir Immune Defic Syndr. 2008;49(3):266–71.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.PubMedCrossRef Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.PubMedCrossRef
17.
Zurück zum Zitat Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O’Shaughnessy MV, Montaner JSG. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002;16(7):1051–8.PubMedCrossRef Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O’Shaughnessy MV, Montaner JSG. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002;16(7):1051–8.PubMedCrossRef
19.
Zurück zum Zitat Safren SA, Biello KB, Smeaton L, Mimiaga MJ, Walawander A, Lama JR, Rana A, Nyirenda M, Kayoyo VM, Samaneka W, Joglekar A, Celentano D, Martinez A, Remmert JE, Nair A, Lalloo UG, Kumarasamy N, Hakim J, Campbell TB. Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial. PLoS ONE. 2014. https://doi.org/10.1371/journal.pone.0104178.CrossRefPubMedPubMedCentral Safren SA, Biello KB, Smeaton L, Mimiaga MJ, Walawander A, Lama JR, Rana A, Nyirenda M, Kayoyo VM, Samaneka W, Joglekar A, Celentano D, Martinez A, Remmert JE, Nair A, Lalloo UG, Kumarasamy N, Hakim J, Campbell TB. Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial. PLoS ONE. 2014. https://​doi.​org/​10.​1371/​journal.​pone.​0104178.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Grierson J, Koelmeyer RL, Smith A, Pitts M. Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians. HIV Med. 2011;12(9):562–9.PubMedCrossRef Grierson J, Koelmeyer RL, Smith A, Pitts M. Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians. HIV Med. 2011;12(9):562–9.PubMedCrossRef
21.
Zurück zum Zitat Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care. 2000;12(3):255–66.PubMedCrossRef Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care. 2000;12(3):255–66.PubMedCrossRef
23.
Zurück zum Zitat Santos AP. Sex and sensibilities podcast: HIV epidemic in the PH. Rappler Manila; 2015. Santos AP. Sex and sensibilities podcast: HIV epidemic in the PH. Rappler Manila; 2015.
25.
Zurück zum Zitat O’Connor C, Leyritana K, Doyle AM, Lewis JJ, Gill R, Salvaña EM. Interactive mobile phone HIV adherence support for men who have sex with men in the Philippines connect for life study: mixed methods approach to intervention development and pilot testing. JMIR Form Res. 2022;6(2):e30811. https://doi.org/10.2196/30811.CrossRefPubMedPubMedCentral O’Connor C, Leyritana K, Doyle AM, Lewis JJ, Gill R, Salvaña EM. Interactive mobile phone HIV adherence support for men who have sex with men in the Philippines connect for life study: mixed methods approach to intervention development and pilot testing. JMIR Form Res. 2022;6(2):e30811. https://​doi.​org/​10.​2196/​30811.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Free C, Phillips G, Galli L, Watson L, Felix L, Edwards P, Patel V, Haines A. The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS Med. 2013;10(1):e100136229.CrossRef Free C, Phillips G, Galli L, Watson L, Felix L, Edwards P, Patel V, Haines A. The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review. PLoS Med. 2013;10(1):e100136229.CrossRef
28.
Zurück zum Zitat Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, Jack W, Habyarimana J, Sadatsafavi M, Najafzadeh M, Marra CA, Estambale B, Ngugi E, Ball TB, Thabane L, Gelmon LJ, Kimani J, Ackers M, Plummer FA. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. The Lancet. 2010;376(9755):1838–45.CrossRef Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, Jack W, Habyarimana J, Sadatsafavi M, Najafzadeh M, Marra CA, Estambale B, Ngugi E, Ball TB, Thabane L, Gelmon LJ, Kimani J, Ackers M, Plummer FA. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. The Lancet. 2010;376(9755):1838–45.CrossRef
29.
Zurück zum Zitat Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS ONE. 2014;9(2):e88166.PubMedPubMedCentralCrossRefADS Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS ONE. 2014;9(2):e88166.PubMedPubMedCentralCrossRefADS
30.
Zurück zum Zitat Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills EJ, Smieja M, Dolovich L, Kouanfack C. The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS ONE. 2012;7(12):6–12.CrossRef Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills EJ, Smieja M, Dolovich L, Kouanfack C. The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS ONE. 2012;7(12):6–12.CrossRef
31.
Zurück zum Zitat Kanters S, Park JJH, Chan K, Socias ME, Ford N, Forrest JI, Thorlund K, Nachega JB, Mills EJ. Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis. Lancet HIV. 2017;4(1):e31–40.PubMedCrossRef Kanters S, Park JJH, Chan K, Socias ME, Ford N, Forrest JI, Thorlund K, Nachega JB, Mills EJ. Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis. Lancet HIV. 2017;4(1):e31–40.PubMedCrossRef
32.
Zurück zum Zitat Mbuagbaw L, Mursleen S, Lytvyn L, Smieja M, Dolovich L, Thabane L. Mobile phone text messaging interventions for HIV and other chronic diseases: an overview of systematic reviews and framework for evidence transfer. BMC Health Serv Res. 2015;15:33.PubMedPubMedCentralCrossRef Mbuagbaw L, Mursleen S, Lytvyn L, Smieja M, Dolovich L, Thabane L. Mobile phone text messaging interventions for HIV and other chronic diseases: an overview of systematic reviews and framework for evidence transfer. BMC Health Serv Res. 2015;15:33.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Mbuagbaw L, Sivaramalingam B, Navarro T, Hobson N, Keepanasseril A, Wilczynski NJ, Haynes BR, Team the PAR. Interventions for enhancing adherence to antiretroviral therapy (ART): a systematic review of high quality studies. AIDS Patient Care STDS. 2015;29(5):248–66.PubMedPubMedCentralCrossRef Mbuagbaw L, Sivaramalingam B, Navarro T, Hobson N, Keepanasseril A, Wilczynski NJ, Haynes BR, Team the PAR. Interventions for enhancing adherence to antiretroviral therapy (ART): a systematic review of high quality studies. AIDS Patient Care STDS. 2015;29(5):248–66.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Aranda-Jan CB, Mohutsiwa-Dibe N, Loukanova S. Systematic review on what works, what does not work and why of implementation of mobile health (mHealth) projects in Africa. BMC Public Health. 2014;14(1):188.PubMedPubMedCentralCrossRef Aranda-Jan CB, Mohutsiwa-Dibe N, Loukanova S. Systematic review on what works, what does not work and why of implementation of mobile health (mHealth) projects in Africa. BMC Public Health. 2014;14(1):188.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Park LG, Howie-Esquivel J, Dracup K. A quantitative systematic review of the efficacy of mobile phone interventions to improve medication adherence. J Adv Nurs. 2014;70(9):1932–53.PubMedCrossRef Park LG, Howie-Esquivel J, Dracup K. A quantitative systematic review of the efficacy of mobile phone interventions to improve medication adherence. J Adv Nurs. 2014;70(9):1932–53.PubMedCrossRef
38.
41.
Zurück zum Zitat Murthy N, Chandrasekharan S, Prakash MP, Ganju A, Peter J, Kaonga N, Mechael P. Effects of an mHealth voice message service (mMitra) on maternal health knowledge and practices of low-income women in India: findings from a pseudo-randomized controlled trial. BMC Public Health. 2020;20(1):1–10.CrossRef Murthy N, Chandrasekharan S, Prakash MP, Ganju A, Peter J, Kaonga N, Mechael P. Effects of an mHealth voice message service (mMitra) on maternal health knowledge and practices of low-income women in India: findings from a pseudo-randomized controlled trial. BMC Public Health. 2020;20(1):1–10.CrossRef
43.
Zurück zum Zitat Parkes-Ratanshi RM, Nabaggala MS, Bwanika AN, Lamorde M, King R, Owarwo N, Odongpiny EAL, Orama R, Castelnuovo B, Kiragga A. Call for life Uganda TM: an RCT using interactive voice response for PLHIV on art. Top Antivir Med. 2019;27(SUPPL 1):405s–6s. Parkes-Ratanshi RM, Nabaggala MS, Bwanika AN, Lamorde M, King R, Owarwo N, Odongpiny EAL, Orama R, Castelnuovo B, Kiragga A. Call for life Uganda TM: an RCT using interactive voice response for PLHIV on art. Top Antivir Med. 2019;27(SUPPL 1):405s–6s.
44.
Zurück zum Zitat Byonanebye DM, Nabaggala MS, Naggirinya AB, Lamorde M, Oseku E, King R, Owarwo N, Laker E, Orama R, Castelnuovo B, Kiragga A, Parkes-Ratanshi R. An interactive voice response software to improve the quality of life of people living with HIV in Uganda: randomized controlled trial. JMIR mHealth uHealth. 2021;9(2):1–16.CrossRef Byonanebye DM, Nabaggala MS, Naggirinya AB, Lamorde M, Oseku E, King R, Owarwo N, Laker E, Orama R, Castelnuovo B, Kiragga A, Parkes-Ratanshi R. An interactive voice response software to improve the quality of life of people living with HIV in Uganda: randomized controlled trial. JMIR mHealth uHealth. 2021;9(2):1–16.CrossRef
45.
Zurück zum Zitat Michie S, Atkins L, West R. The behaviour change wheel: a guide to designing interventions. 2014. ISBN:978-1-291-84605-8. Michie S, Atkins L, West R. The behaviour change wheel: a guide to designing interventions. 2014. ISBN:978-1-291-84605-8.
46.
Zurück zum Zitat Fisher JD, Amico KR, Fisher WA, Harman JJ. The information-motivation-behavioral skills model of antiretroviral adherence and its applications. Curr HIV/AIDS Rep. 2008;5(4):193–203.PubMedCrossRef Fisher JD, Amico KR, Fisher WA, Harman JJ. The information-motivation-behavioral skills model of antiretroviral adherence and its applications. Curr HIV/AIDS Rep. 2008;5(4):193–203.PubMedCrossRef
47.
Zurück zum Zitat Krishnan A, Ferro EG, Weikum D, Vagenas P, Lama JR, Sanchez J, Altice FL. Communication technology use and mHealth acceptance among HIV-infected men who have sex with men in Peru: implications for HIV prevention and treatment. AIDS Care. 2014;0121(October):1–10. Krishnan A, Ferro EG, Weikum D, Vagenas P, Lama JR, Sanchez J, Altice FL. Communication technology use and mHealth acceptance among HIV-infected men who have sex with men in Peru: implications for HIV prevention and treatment. AIDS Care. 2014;0121(October):1–10.
48.
Zurück zum Zitat Uhrig JD, Lewis MA, Bann CM, Harris JL, Furberg D, Coomes CM, Kuhns LM, Uhrig JD, Lewis MA, Bann CM, Harris JL, Furberg RD, Coomes CM, Kuhns LM, Hiv A, Uhrig JD, Lewis MA, Bann CM, Harris JL, Furberg RD, Coomes CM, Kuhns LM. Addressing HIV knowledge, risk reduction, social support, and patient involvement using SMS: results of a proof-of-concept study addressing HIV knowledge, risk reduction, social support, and patient involvement using SMS: results of a proof-of-con. J Health Commun. 2012;17(Sup1):128–45. https://doi.org/10.1080/10810730.2011.649156.CrossRefPubMed Uhrig JD, Lewis MA, Bann CM, Harris JL, Furberg D, Coomes CM, Kuhns LM, Uhrig JD, Lewis MA, Bann CM, Harris JL, Furberg RD, Coomes CM, Kuhns LM, Hiv A, Uhrig JD, Lewis MA, Bann CM, Harris JL, Furberg RD, Coomes CM, Kuhns LM. Addressing HIV knowledge, risk reduction, social support, and patient involvement using SMS: results of a proof-of-concept study addressing HIV knowledge, risk reduction, social support, and patient involvement using SMS: results of a proof-of-con. J Health Commun. 2012;17(Sup1):128–45. https://​doi.​org/​10.​1080/​10810730.​2011.​649156.CrossRefPubMed
50.
Zurück zum Zitat Schnall R, Travers J, Rojas M, Carballo-Diéguez A. eHealth interventions for HIV prevention in high-risk men who have sex with men: a systematic review. J Med Internet Res. 2014;16(5):1–10.CrossRef Schnall R, Travers J, Rojas M, Carballo-Diéguez A. eHealth interventions for HIV prevention in high-risk men who have sex with men: a systematic review. J Med Internet Res. 2014;16(5):1–10.CrossRef
52.
Zurück zum Zitat World Health Organization. WHOQOL-HIV BREF, 2012 revision. Geneva: World Health Organization; 2002. World Health Organization. WHOQOL-HIV BREF, 2012 revision. Geneva: World Health Organization; 2002.
53.
Zurück zum Zitat World Health Organization. WHOQOL-HIV instrument: scoring and coding for the WHOQOL-HIV instruments: users manual, 2012 revision. WHOQOL-HIV instrument users manual. Geneva: World Health Organization; 2002. World Health Organization. WHOQOL-HIV instrument: scoring and coding for the WHOQOL-HIV instruments: users manual, 2012 revision. WHOQOL-HIV instrument users manual. Geneva: World Health Organization; 2002.
55.
Zurück zum Zitat Carliner H, Mauro PM, Brown QL, Shmulewitz D, Rahim-Juwel R, Sarvet AL, Wall MM, Martins SS, Carliner G, Hasin DS. Key substance use and mental health indicators in the United States. Drug Alcohol Depend. 2017;170:51–8.PubMedCrossRef Carliner H, Mauro PM, Brown QL, Shmulewitz D, Rahim-Juwel R, Sarvet AL, Wall MM, Martins SS, Carliner G, Hasin DS. Key substance use and mental health indicators in the United States. Drug Alcohol Depend. 2017;170:51–8.PubMedCrossRef
57.
Zurück zum Zitat Dutra BS, Lédo AP, Lins-Kusterer L, Luz E, Prieto IR, Brites C. Changes health-related quality of life in HIV-infected patients following initiation of antiretroviral therapy: a longitudinal study. Braz J Infect Dis. 2019;23(4):211–7.PubMedPubMedCentralCrossRef Dutra BS, Lédo AP, Lins-Kusterer L, Luz E, Prieto IR, Brites C. Changes health-related quality of life in HIV-infected patients following initiation of antiretroviral therapy: a longitudinal study. Braz J Infect Dis. 2019;23(4):211–7.PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Philippines Department of Health. Department of Health Administrative order 2014-0031: policies and guidelines on the use of antiretroviral therapy (ART) among people living with human immunodeficiency virus and HIV-exposed infants. 2014. Philippines Department of Health. Department of Health Administrative order 2014-0031: policies and guidelines on the use of antiretroviral therapy (ART) among people living with human immunodeficiency virus and HIV-exposed infants. 2014.
61.
Zurück zum Zitat Salvana EMT, Samonte GMJ, Telan E, Leyritana K, Tactacan-Abrenica RJ, Ching PR, Arevalo GM, Dungca NT, Peñalosa-Ramos C, Mendoza KAR, Trinidad LF, dela Tonga A, Lim J, Destura R, Alejandria M, Solante R, Arcangel L, Palaypayon NS, Schwem BE. High rates of tenofovir failure in a CRF01_AE-predominant HIV epidemic in the Philippines. Int J Infect Dis Int Soc Infect Dis. 2020;95:125–32.CrossRef Salvana EMT, Samonte GMJ, Telan E, Leyritana K, Tactacan-Abrenica RJ, Ching PR, Arevalo GM, Dungca NT, Peñalosa-Ramos C, Mendoza KAR, Trinidad LF, dela Tonga A, Lim J, Destura R, Alejandria M, Solante R, Arcangel L, Palaypayon NS, Schwem BE. High rates of tenofovir failure in a CRF01_AE-predominant HIV epidemic in the Philippines. Int J Infect Dis Int Soc Infect Dis. 2020;95:125–32.CrossRef
64.
Zurück zum Zitat Peng W, Song X, Zhang C, Chen Y, Zhou Q, Välimäki MA, Li X. The proportion of HIV disclosure to sexual partners among people diagnosed with HIV in China: a systematic review and meta-analysis. Front Public Health. 2022;10:1004869.PubMedPubMedCentralCrossRef Peng W, Song X, Zhang C, Chen Y, Zhou Q, Välimäki MA, Li X. The proportion of HIV disclosure to sexual partners among people diagnosed with HIV in China: a systematic review and meta-analysis. Front Public Health. 2022;10:1004869.PubMedPubMedCentralCrossRef
66.
Zurück zum Zitat O’Connor C, Leyritana K, Calica K, Gill R, Doyle AM, Lewis JJ, Salvaña EM. Risk factors affecting adherence to antiretroviral therapy among HIV patients in Manila, Philippines: a baseline cross-sectional analysis of the Philippines Connect for Life Study. Sex Health. 2021;18(1):95–103.PubMedCrossRef O’Connor C, Leyritana K, Calica K, Gill R, Doyle AM, Lewis JJ, Salvaña EM. Risk factors affecting adherence to antiretroviral therapy among HIV patients in Manila, Philippines: a baseline cross-sectional analysis of the Philippines Connect for Life Study. Sex Health. 2021;18(1):95–103.PubMedCrossRef
67.
Zurück zum Zitat Hoenigl M, Chaillon A, Moore DJ, Morris SR, Smith DM, Little SJ. Clear links between starting methamphetamine and increasing sexual risk behavior: a cohort study among men who have sex with men clear links between starting methamphetamine and increasing sexual risk behavior: a cohort study among men who have sex with me. J Acquir Immune Defic Syndr. 2016;71(5):551–7. https://doi.org/10.1097/QAI.0000000000000888.CrossRefPubMedPubMedCentral Hoenigl M, Chaillon A, Moore DJ, Morris SR, Smith DM, Little SJ. Clear links between starting methamphetamine and increasing sexual risk behavior: a cohort study among men who have sex with men clear links between starting methamphetamine and increasing sexual risk behavior: a cohort study among men who have sex with me. J Acquir Immune Defic Syndr. 2016;71(5):551–7. https://​doi.​org/​10.​1097/​QAI.​0000000000000888​.CrossRefPubMedPubMedCentral
72.
Zurück zum Zitat Da Costa TM, Barbosa BJP, Gomes e Costa DA, Sigulem D, De Fátima Marin H, Filho AC, Pisa IT. Results of a randomized controlled trial to assess the effects of a mobile SMS-based intervention on treatment adherence in HIV/AIDS-infected Brazilian women and impressions and satisfaction with respect to incoming messages. Int J Med Inform. 2012;81(4):257–69.PubMedPubMedCentralCrossRef Da Costa TM, Barbosa BJP, Gomes e Costa DA, Sigulem D, De Fátima Marin H, Filho AC, Pisa IT. Results of a randomized controlled trial to assess the effects of a mobile SMS-based intervention on treatment adherence in HIV/AIDS-infected Brazilian women and impressions and satisfaction with respect to incoming messages. Int J Med Inform. 2012;81(4):257–69.PubMedPubMedCentralCrossRef
73.
Zurück zum Zitat Orrell C, Cohen K, Mauff K, Bangsberg DR, Maartens G, Wood R. A randomized controlled trial of real-time electronic adherence monitoring with text message dosing reminders in people starting first-line antiretroviral therapy. J Acquir Immune Defic Syndr. 2015;70(5):495–502.PubMedCrossRef Orrell C, Cohen K, Mauff K, Bangsberg DR, Maartens G, Wood R. A randomized controlled trial of real-time electronic adherence monitoring with text message dosing reminders in people starting first-line antiretroviral therapy. J Acquir Immune Defic Syndr. 2015;70(5):495–502.PubMedCrossRef
74.
Zurück zum Zitat Haberer JE, Musiimenta A, Atukunda EC, Musinguzi N, Wyatt MA, Ware NC, Bangsberg DR. Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS. 2016;30(8):1295–9.PubMedCrossRef Haberer JE, Musiimenta A, Atukunda EC, Musinguzi N, Wyatt MA, Ware NC, Bangsberg DR. Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS. 2016;30(8):1295–9.PubMedCrossRef
75.
Zurück zum Zitat Dillingham R, Ingersoll K, Flickinger TE, Waldman AL, Grabowski M, Laurence C, Wispelwey E, Reynolds G, Conaway M, Cohn WF. PositiveLinks: a mobile health intervention for retention in HIV care and clinical outcomes with 12-month follow-up. AIDS Patient Care STDS. 2018;32(6):241–50.PubMedPubMedCentralCrossRef Dillingham R, Ingersoll K, Flickinger TE, Waldman AL, Grabowski M, Laurence C, Wispelwey E, Reynolds G, Conaway M, Cohn WF. PositiveLinks: a mobile health intervention for retention in HIV care and clinical outcomes with 12-month follow-up. AIDS Patient Care STDS. 2018;32(6):241–50.PubMedPubMedCentralCrossRef
79.
Zurück zum Zitat Hung CC, Banerjee S, Gilada I, Green K, Inoue Y, Kamarulzaman A, Leyritana K, Phanuphak N, Wong T, Wong TH, Singh S, Choi JY. Impact of COVID-19 on the HIV care continuum in Asia: insights from people living with HIV, key populations, and HIV healthcare providers. PLoS ONE. 2022;17(7):1–18.CrossRef Hung CC, Banerjee S, Gilada I, Green K, Inoue Y, Kamarulzaman A, Leyritana K, Phanuphak N, Wong T, Wong TH, Singh S, Choi JY. Impact of COVID-19 on the HIV care continuum in Asia: insights from people living with HIV, key populations, and HIV healthcare providers. PLoS ONE. 2022;17(7):1–18.CrossRef
80.
Zurück zum Zitat Finitsis DJ, Pellowski JA, Huedo-Medina TB, Fox MC, Kalichman SC. Visual analogue scale (VAS) measurement of antiretroviral adherence in people living with HIV (PLWH): a meta-analysis. J Behav Med. 2016;39(6):1043–55.PubMedCrossRef Finitsis DJ, Pellowski JA, Huedo-Medina TB, Fox MC, Kalichman SC. Visual analogue scale (VAS) measurement of antiretroviral adherence in people living with HIV (PLWH): a meta-analysis. J Behav Med. 2016;39(6):1043–55.PubMedCrossRef
81.
Zurück zum Zitat Kabore L, Muntner P, Chamot E, Zinski A, Burkholder G, Mugavero MJ. Self-report measures in the assessment of antiretroviral medication adherence: comparison with medication possession ratio and HIV viral load. J Int Assoc Provid AIDS Care. 2015;14(2):156–62.PubMedCrossRef Kabore L, Muntner P, Chamot E, Zinski A, Burkholder G, Mugavero MJ. Self-report measures in the assessment of antiretroviral medication adherence: comparison with medication possession ratio and HIV viral load. J Int Assoc Provid AIDS Care. 2015;14(2):156–62.PubMedCrossRef
82.
Zurück zum Zitat Buscher A, Hartman C, Kallen M, Giordano T. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-Naïve, HIV patients. HIV Clin Trials. 2011;12(5):244–54.PubMedPubMedCentralCrossRef Buscher A, Hartman C, Kallen M, Giordano T. Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-Naïve, HIV patients. HIV Clin Trials. 2011;12(5):244–54.PubMedPubMedCentralCrossRef
Metadaten
Titel
Changes in Adherence and Viral Load Suppression Among People with HIV in Manila: Outcomes of the Philippines Connect for Life Study
verfasst von
Cara O’Connor
Katerina Leyritana
Aoife M. Doyle
James J. Lewis
Edsel Maurice Salvaña
Publikationsdatum
04.10.2023
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 3/2024
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-023-04190-1

Weitere Artikel der Ausgabe 3/2024

AIDS and Behavior 3/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.